日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target

载脂蛋白C-III:风险因素、富含甘油三酯脂蛋白代谢的调节因子和治疗靶点

Björnson, Elias; Adiels, Martin; Taskinen, Marja-Riitta; Packard, Chris J; Borén, Jan

Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia

高剂量二十碳五烯酸在预防高甘油三酯血症患者心血管疾病中的应用概念与实践

Roger, Guillaume; Packard, Chris J; Masana, Luis; Laufs, Ulrich; Catapano, Alberico L; Steg, Philippe Gabriel

Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol

利用非高密度脂蛋白胆固醇量化富含甘油三酯的脂蛋白的致动脉粥样硬化性、与炎症的关联及其对风险评估的意义

Björnson, Elias; Adiels, Martin; Gummesson, Anders; Taskinen, Marja-Riitta; Burgess, Stephen; Packard, Chris J; Borén, Jan

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

脂蛋白(a)比低密度脂蛋白(LDL)更具致动脉粥样硬化作用:基于载脂蛋白B的基因分析

Björnson, Elias; Adiels, Martin; Taskinen, Marja-Riitta; Burgess, Stephen; Chapman, M John; Packard, Chris J; Borén, Jan

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

探索载脂蛋白C-III:病理生理学和药理学意义

Packard, Chris J; Pirillo, Angela; Tsimikas, Sotirios; Ference, Brian A; Catapano, Alberico L

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

富含甘油三酯的脂蛋白残粒、低密度脂蛋白与冠心病风险:一项英国生物银行研究

Björnson, Elias; Adiels, Martin; Taskinen, Marja-Riitta; Burgess, Stephen; Rawshani, Aidin; Borén, Jan; Packard, Chris J

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy

肠道富含甘油三酯的脂蛋白对接受他汀类药物治疗的2型糖尿病患者残余动脉粥样硬化性心血管疾病风险的贡献

Taskinen, Marja-Riitta; Matikainen, Niina; Björnson, Elias; Söderlund, Sanni; Inkeri, Jussi; Hakkarainen, Antti; Parviainen, Helka; Sihlbom, Carina; Thorsell, Annika; Andersson, Linda; Adiels, Martin; Packard, Chris J; Borén, Jan

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

富含甘油三酯的脂蛋白及其残余物:代谢见解、在动脉粥样硬化性心血管疾病中的作用以及新兴治疗策略——欧洲动脉粥样硬化协会共识声明

Ginsberg, Henry N; Packard, Chris J; Chapman, M John; Borén, Jan; Aguilar-Salinas, Carlos A; Averna, Maurizio; Ference, Brian A; Gaudet, Daniel; Hegele, Robert A; Kersten, Sander; Lewis, Gary F; Lichtenstein, Alice H; Moulin, Philippe; Nordestgaard, Børge G; Remaley, Alan T; Staels, Bart; Stroes, Erik S G; Taskinen, Marja-Riitta; Tokgözoğlu, Lale S; Tybjaerg-Hansen, Anne; Stock, Jane K; Catapano, Alberico L

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine

腺苷酸环化酶 9 在达塞曲匹药物基因组学反应中的作用:精准心血管医学中的临床范式和分子机制

Rhainds, David; Packard, Chris J; Brodeur, Mathieu R; Niesor, Eric J; Sacks, Frank M; Jukema, J Wouter; Wright, R Scott; Waters, David D; Heinonen, Therese; Black, Donald M; Laghrissi-Thode, Fouzia; Dubé, Marie-Pierre; Pfeffer, Marc A; Tardif, Jean-Claude

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

低密度脂蛋白导致动脉粥样硬化性心血管疾病:病理生理学、遗传学和治疗学见解:欧洲动脉粥样硬化学会共识小组的共识声明

Borén, Jan; Chapman, M John; Krauss, Ronald M; Packard, Chris J; Bentzon, Jacob F; Binder, Christoph J; Daemen, Mat J; Demer, Linda L; Hegele, Robert A; Nicholls, Stephen J; Nordestgaard, Børge G; Watts, Gerald F; Bruckert, Eric; Fazio, Sergio; Ference, Brian A; Graham, Ian; Horton, Jay D; Landmesser, Ulf; Laufs, Ulrich; Masana, Luis; Pasterkamp, Gerard; Raal, Frederick J; Ray, Kausik K; Schunkert, Heribert; Taskinen, Marja-Riitta; van de Sluis, Bart; Wiklund, Olov; Tokgozoglu, Lale; Catapano, Alberico L; Ginsberg, Henry N